SCHEMBL19554209

SCHEMBL19554209

COC(=O)NCc1cn(-c2cccc(N3CCN(C)c4nc(SC)ncc4C3=O)c2)cn1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 20/20 0.60
SLC6A2 P23975 12/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19553735 0.88 CACNA2D1 (0.60) CACNA2D1SLC6A2
SCHEMBL21747611 0.86 CACNA2D1 (0.60) CACNA2D1SLC6A2
SCHEMBL19554143 0.85 CACNA2D1 (0.60) CACNA2D1SLC6A2
SCHEMBL19554205 0.84 CACNA2D1 (0.62) CACNA2D1SLC6A2
SCHEMBL19553830 0.83 CACNA2D1 (0.63) CACNA2D1SLC6A2
SCHEMBL21747631 0.82 CACNA2D1 (0.61) CACNA2D1SLC6A2
SCHEMBL20970720 0.82 CACNA2D1 (0.63) CACNA2D1SLC6A2
SCHEMBL20970771 0.82 CACNA2D1 (0.61) CACNA2D1SLC6A2
SCHEMBL19553427 0.81 CACNA2D1 (0.54) CACNA2D1SLC6A2
SCHEMBL21747682 0.81 CACNA2D1 (0.57) CACNA2D1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452475-B1 TETRAHYDROPYRIMIDODIAZEPINE AND TETRAHYDROPYRIDODIAZEPINE COMPOUNDS FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS SA (ES) 2020-02-26 EP claimed
EP-3452475-A1 TETRAHYDROPYRIMIDODIAZEPINE AND TETRAHYDROPYRIDODIAZEPINE COMPOUNDS FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-03-13 EP disclosed
WO-2017191304-A1 TETRAHYDROPYRIMIDODIAZEPINE AND TETRAHYDROPYRIDODIAZEPINE COMPOUNDS FOR TREATING PAIN AND PAIN RELATED CONDITIONS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2017-11-09 WO disclosed